Literature DB >> 7921584

Pathology of inflammatory demyelinating neuropathies.

J W Prineas1.   

Abstract

GBS and CIDP are multifocal demyelinating diseases with lesions widely disseminated throughout the peripheral nervous system including cranial nerves, terminal intramuscular nerves and autonomic nerves. In both conditions myelin destruction is mediated by macrophages that attack myelin without disturbing the integrity of Schwann cells. The same pattern of myelin breakdown occurs in EAN, providing additional evidence that these disorders are immune-mediated. Recent autopsy and biopsy studies have challenged the view that lymphocytes are always present in newly forming lesions, an observation supporting a role for humoral immunity in the pathogenesis of some cases of GBS and CIDP. In both conditions neurological dysfunction is related to both myelin destruction and axonal loss. In some cases of CIDP there is the additional factor of impaired remyelination. Other chronic demyelinating neuropathies that may be immune-mediated differ from CIDP in presenting as solitary or multiple mononeuropathies. These can be classified into cases with and without evidence of widespread demyelination, cases with and without focal nerve enlargements, and a pure motor variant, multiple motor neuropathy associated with elevated anti-GM1 ganglioside antibody titres.

Entities:  

Mesh:

Year:  1994        PMID: 7921584

Source DB:  PubMed          Journal:  Baillieres Clin Neurol        ISSN: 0961-0421


  5 in total

Review 1.  Chronic inflammatory demyelinative polyneuropathy.

Authors:  Gérard Said
Journal:  J Neurol       Date:  2002-03       Impact factor: 4.849

2.  A case of cauda equina syndrome in early-onset chronic inflammatory demyelinating polyneuropathy clinically similar to charcot-marie-tooth disease type 1.

Authors:  Seung Eun Lee; Seung Won Park; Sam Yeol Ha; Taek Kyun Nam
Journal:  J Korean Neurosurg Soc       Date:  2014-06-30

3.  Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  R Press; M Pashenkov; J P Jin; H Link
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

4.  Dapsone reduced cuprizone-induced demyelination via targeting Nrf2 and IKB in C57BL/6 mice.

Authors:  Ahmad Reza Dehpour; Ehsan Khaledi; Tayebeh Noori; Ahmad Mohammadi-Farani; Ladan Delphi; Antoni Sureda; Eduardo Sobarzo-Sanchez; Samira Shirooie
Journal:  Iran J Basic Med Sci       Date:  2022-06       Impact factor: 2.532

5.  Differential Expression of miRNAs and Behavioral Change in the Cuprizone-Induced Demyelination Mouse Model.

Authors:  Seung Ro Han; Yun Hee Kang; Hyungtaek Jeon; Suhyuk Lee; Sang-Jin Park; Dae-Yong Song; Sun Seek Min; Seung-Min Yoo; Myung-Shin Lee; Seung-Hoon Lee
Journal:  Int J Mol Sci       Date:  2020-01-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.